Avidity Partners Management LP Aldeyra Therapeutics, Inc. Transaction History

Avidity Partners Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$7.94 - $11.31 $11.5 Million - $16.4 Million	-1,450,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$10.44 - $14.85 $11.5 Million - $16.4 Million	-1,102,000 Reduced 43.18%	1,450,000 $16.4 Million
Q1 2021 May 17, 2021	BUY	$6.53 - $14.42 $7.29 Million - $16.1 Million	1,117,000 Added 77.84%	2,552,000 $30.3 Million
Q4 2020 Feb 16, 2021	BUY	$6.31 - $8.13 $31,549 - $40,650	5,000 Added 0.35%	1,435,000 $9.84 Million
Q3 2020 Nov 16, 2020	BUY	$4.0 - $7.53 $5.72 Million - $10.8 Million	1,430,000 New	1,430,000 $10.6 Million

130

38M

764K

544K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $379M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.